patent analysis in this report are remdesivir, ruxolitinib and favipiravir, and the biotherapeutics tocilizumab, siltuximab … support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the …

Since COVID-19 was first identified, infections from the virus and the death toll have spiked abysmally. The pandemic … and psychological ramifications associated with the pandemic are also immense. The threat posed by COVID-19 on global … health and the economic downturn resulting thereof necessitates the development of health technologies (such as medicines and …

The COVID-19 pandemic has caused Governments to contemplate measures to override patents and other intellectual … devices. This paper discusses whether the COVID-19 pandemic may be considered an “emergency in international relations” and … overriding IPRs otherwise required to be made available or enforced. It concludes that the pandemic constitutes an emergency in …

prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing … countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent … applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines …

Like other rights, patent rights are not absolute. There are situations in which their exercise can be limited to …, that can specifically be used to address public health needs. This document is intended to provide legal guidance for the …

Like other rights, patent rights are not absolute. There are situations in which their exercise can be limited to …, that can specifically be used to address public health needs. This document is intended to provide legal guidance for the …

patent infringement, particularly if “reasonable compensation” is offered in the form of an “ongoing royalty” or an “interim … pharmaceutical regulatory approvals to the patent system and imposing stays of such approvals normally avoid the need for such …

The unprecedented global health crisis caused by the coronavirus (COVID-19) pandemic since the first quarter of 2020 … has reopened the now-urgent discussion about the role of local pharmaceutical production in addressing the health needs in …’ or ‘health security’. If this becomes a reality and the production of pharmaceuticals is led by nationalistic policies …

La crise sanitaire mondiale sans précédent provoquée par la pandémie de coronavirus (COVID-19), au cours du premier …